ARCHIVES

Wyden Asks Healy To Clarify CRADA Pricing Clause

This article is from The Cancer Letter archive.

Vol. 18 No. 01 | January 3, 1992

Download PDF Visit The Full Archive

Related Articles

Adjuvant Chemo Improves Survival In Early Lung Cancer

July 30, 2004

Varmus: Why are scientific societies obstructing public access to research results?

May 20, 2005

ASCO TO NCI: Review Auditing Procedures, Re-Establish Trust

May 27, 1994

ODAC Recommends Approval of Gemcitabine For Pancreatic Cancer

August 4, 1995

Health Organizations: ACS Statement Supports funding of Research On Human Stem cells

December 17, 1999

Officals: “Separations” in Normal Range as Critics Claim Brain Drain in the Clinic

January 17, 2014